Skip to main content
Top
Published in: Journal of Assisted Reproduction and Genetics 5/2020

01-05-2020 | Fertility | Letter to Editor

Fertility preservation strategies in borderline ovarian tumor recurrences: different sides of the same coin

Authors: Barbara Buonomo, Fedro A Peccatori

Published in: Journal of Assisted Reproduction and Genetics | Issue 5/2020

Login to get access

Excerpt

Borderline ovarian tumors (BOT) account for 10–20% of all ovarian epithelial tumors, with one-third of cases diagnosed under the age of 40 [1]. Fertility-sparing surgery (FSS) can be offered to patients who wish to spare their reproductive potential, even if the overall risk of recurrence after FSS is higher (0–25%) than after bilateral salpingo-oophorectomy (0–5%) [2, 3]. The management of patients who recur after FSS is challenging. Although a second FSS can be offered [4, 5], repeated surgery may reduce healthy ovarian parenchyma, increasing the risk of infertility [6]. Moreover, the occurrence of postoperative adhesions might interfere with fallopian tube function [7]. Thus, for a patient undergoing FSS and interested in having a pregnancy, the best option is to achieve pregnancy through spontaneous conception immediately after first surgery, acknowledging the higher recurrence rate during the first 2 years [810] and that pregnancy does not increase this risk [1114]. In situations involving a personal history of infertility or when reproduction is not desired by patients yet, the most appropriate plan B is to rely on assisted reproductive techniques (ARTs), with oocyte harvesting and cryopreservation after FSS [15]. …
Literature
1.
go back to reference Skirnisdottir I, Garmo H, Wilander E, Holmberg L. Borderline ovarian tumors in Sweden 1960–2005: trends in incidence and age at diagnosis compared to ovarian cancer. Int J Cancer. 2008;123:1897–901.CrossRef Skirnisdottir I, Garmo H, Wilander E, Holmberg L. Borderline ovarian tumors in Sweden 1960–2005: trends in incidence and age at diagnosis compared to ovarian cancer. Int J Cancer. 2008;123:1897–901.CrossRef
4.
go back to reference Uzan C, Muller E, Kane A, et al. Fertility sparing treatment of recurrent stage I serous borderline ovarian tumors. Hum Reprod. 2013;12:3222–6.CrossRef Uzan C, Muller E, Kane A, et al. Fertility sparing treatment of recurrent stage I serous borderline ovarian tumors. Hum Reprod. 2013;12:3222–6.CrossRef
5.
go back to reference Prat J. The results of conservative (fertility-sparing) treatment in borderline ovarian tumors vary depending on age and histological type. Ann Oncol. 2014;25:1255–8.CrossRef Prat J. The results of conservative (fertility-sparing) treatment in borderline ovarian tumors vary depending on age and histological type. Ann Oncol. 2014;25:1255–8.CrossRef
6.
go back to reference Somigliana E, Ragni G, Infantino M, Benedetti F, Arnoldi M, Crosignani PG. Does laparoscopic removal of nonendometriotic benign ovarian cysts affect ovarian reserve? Acta Obstet Gynecol Scand. 2006;85:74–7.CrossRef Somigliana E, Ragni G, Infantino M, Benedetti F, Arnoldi M, Crosignani PG. Does laparoscopic removal of nonendometriotic benign ovarian cysts affect ovarian reserve? Acta Obstet Gynecol Scand. 2006;85:74–7.CrossRef
7.
go back to reference Bolnick A, Bolnick J, Diamond MP. Postoperative adhesions as a consequence of pelvic surgery. J Minim Invasive Gynecol. 2015;22:549–63.CrossRef Bolnick A, Bolnick J, Diamond MP. Postoperative adhesions as a consequence of pelvic surgery. J Minim Invasive Gynecol. 2015;22:549–63.CrossRef
8.
go back to reference Darai E, Teboul J, Fauconnier A, Scoazec JY, Benifla JL, Madelenat P. Management and outcome of borderline ovarian tumors incidentally discovered at or after laparoscopy. Acta Obstet Gynecol Scand. 1998;77:451–7.CrossRef Darai E, Teboul J, Fauconnier A, Scoazec JY, Benifla JL, Madelenat P. Management and outcome of borderline ovarian tumors incidentally discovered at or after laparoscopy. Acta Obstet Gynecol Scand. 1998;77:451–7.CrossRef
9.
go back to reference Trope CG, Kristensen G, Makar A. Surgery for borderline tumor of the ovary. Semin Surg Oncol. 2000;19:69–75.CrossRef Trope CG, Kristensen G, Makar A. Surgery for borderline tumor of the ovary. Semin Surg Oncol. 2000;19:69–75.CrossRef
10.
go back to reference Trimble EL, Trimble LC. Epithelial ovarian tumors of low malignant potential. In: Markman M, Hoskins WJ, editors. Cancer of the ovary. New York: Raven Press; 1993. p. 415–29. Trimble EL, Trimble LC. Epithelial ovarian tumors of low malignant potential. In: Markman M, Hoskins WJ, editors. Cancer of the ovary. New York: Raven Press; 1993. p. 415–29.
11.
go back to reference Seracchioli R, Venturoli S, Colombo FM, Govoni F, Missiroli S, Bagnoli A. Fertility and tumor recurrence rate after conservative Lapa- roscopic management of young women with early-stage borderline ovarian tumors. Fertil Steril. 2001;76:999–1004.CrossRef Seracchioli R, Venturoli S, Colombo FM, Govoni F, Missiroli S, Bagnoli A. Fertility and tumor recurrence rate after conservative Lapa- roscopic management of young women with early-stage borderline ovarian tumors. Fertil Steril. 2001;76:999–1004.CrossRef
12.
go back to reference Donnez J, Munschke A, Berliere M, Pirard C, Jadoul P, Smets M, et al. Safety of conservative management and fertility outcome in women with borderline tumors of the ovary. Fertil Steril. 2003;79:1216–21.CrossRef Donnez J, Munschke A, Berliere M, Pirard C, Jadoul P, Smets M, et al. Safety of conservative management and fertility outcome in women with borderline tumors of the ovary. Fertil Steril. 2003;79:1216–21.CrossRef
13.
go back to reference Morice P, Camatte S, El Hassan J, Pautier P, Duvillard P, Castaigne D. Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil Steril. 2001;75:92–6.CrossRef Morice P, Camatte S, El Hassan J, Pautier P, Duvillard P, Castaigne D. Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil Steril. 2001;75:92–6.CrossRef
14.
go back to reference Gotlieb WH, Flikker S, Davidson B, Korach Y, Kopolovic J, Ben-Baruch G. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome. Cancer. 1998;82:141–6.CrossRef Gotlieb WH, Flikker S, Davidson B, Korach Y, Kopolovic J, Ben-Baruch G. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome. Cancer. 1998;82:141–6.CrossRef
17.
go back to reference Franchi D, Boveri S, Fruscio R, Fischerova D, Guerriero S, Moruzzi MC, et al. Imaging in gynecological disease (8): ultrasound characteristics of recurrent borderline ovarian tumors. Ultrasound Obstet Gynecol. 2013;41:452–8.CrossRef Franchi D, Boveri S, Fruscio R, Fischerova D, Guerriero S, Moruzzi MC, et al. Imaging in gynecological disease (8): ultrasound characteristics of recurrent borderline ovarian tumors. Ultrasound Obstet Gynecol. 2013;41:452–8.CrossRef
18.
go back to reference Morice P, Uzan C, Fauvet R, Gouy S, Duvillard P, Darai E. Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence. Lancet Oncol. 2012;13:e103–15.CrossRef Morice P, Uzan C, Fauvet R, Gouy S, Duvillard P, Darai E. Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence. Lancet Oncol. 2012;13:e103–15.CrossRef
19.
go back to reference Tourgeman DE, Lu JJ, Boostanfar R, Amezcua C, Felix JC, Paulson RJ. Human chorionic gonadotropin suppresses ovarian epithelial neoplastic cell proliferation in vitro. Fertil Steril. 2002;78:1096–9.CrossRef Tourgeman DE, Lu JJ, Boostanfar R, Amezcua C, Felix JC, Paulson RJ. Human chorionic gonadotropin suppresses ovarian epithelial neoplastic cell proliferation in vitro. Fertil Steril. 2002;78:1096–9.CrossRef
20.
go back to reference Basille C, Olivennes F, Le Calvez J, Beron-Gaillard N, Meduri G, Lhommé C, et al. Impact of gonadotrophins and steroid hormones on tumour cells derived from borderline ovarian tumours. Hum Reprod. 2006;21:3241–5.CrossRef Basille C, Olivennes F, Le Calvez J, Beron-Gaillard N, Meduri G, Lhommé C, et al. Impact of gonadotrophins and steroid hormones on tumour cells derived from borderline ovarian tumours. Hum Reprod. 2006;21:3241–5.CrossRef
24.
go back to reference Yasui T, Hayashi K, Mizunuma H, Kubota T, Aso T, Matsumura Y, et al. Factors associated with premature ovarian failure, early menopause and earlier onset of menopause in Japanese women. Maturitas. 2012;72:249–55.CrossRef Yasui T, Hayashi K, Mizunuma H, Kubota T, Aso T, Matsumura Y, et al. Factors associated with premature ovarian failure, early menopause and earlier onset of menopause in Japanese women. Maturitas. 2012;72:249–55.CrossRef
25.
go back to reference Bjelland EK, Wilkosz P, Tanbo TG, Eskild A. Is unilateral oophorectomy associated with age at menopause? A population study (the HUNT2 survey). Hum Reprod. 2014;29:835–41.CrossRef Bjelland EK, Wilkosz P, Tanbo TG, Eskild A. Is unilateral oophorectomy associated with age at menopause? A population study (the HUNT2 survey). Hum Reprod. 2014;29:835–41.CrossRef
29.
go back to reference Fauvet R, Poncelet C, Boccara J, Descamps P, Fondrinier E, Daraï E. Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study. Fertil Steril. 2005;83(2):284–90 quiz 525-6.CrossRef Fauvet R, Poncelet C, Boccara J, Descamps P, Fondrinier E, Daraï E. Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study. Fertil Steril. 2005;83(2):284–90 quiz 525-6.CrossRef
Metadata
Title
Fertility preservation strategies in borderline ovarian tumor recurrences: different sides of the same coin
Authors
Barbara Buonomo
Fedro A Peccatori
Publication date
01-05-2020
Publisher
Springer US
Keyword
Fertility
Published in
Journal of Assisted Reproduction and Genetics / Issue 5/2020
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-020-01738-1

Other articles of this Issue 5/2020

Journal of Assisted Reproduction and Genetics 5/2020 Go to the issue